Supervising gene therapy, openly.
D026683:Advisory Committees; D000818:Animals; D004274:DNA, Recombinant; D035082:Federal Government; D015316:Genetic Therapy / Q000009:adverse effects / Q000331:legislation & jurisprudence / Q000592:standards*; D005822:Genetic Vectors / Q000009:adverse effects / Q000592:standards; D033161:Government Regulation; D006801:Humans; D009316:National Institutes of Health (U.S.); D011050:Policy Making; D018570:Risk Assessment; D012449:Safety; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration
D004274:DNA, Recombinant